Patent Assignment
Reel/Frame 040453/0741
Assignment of Assignor's Interest
Recorded: 2016-11-29
Pages: 4
Assignee
MERRIMACK PHARMACEUTICALS, INC.
ONE KENDALL SQUARE, SUITE B7201, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Property
(1)
Use of ERBB3 Inhibitors in the Treatment of Triple Negative and Basal-Like Breast Cancers
Application:
15/346,439 →
Publication:
US 2017/0291957